The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

25 articles for JW Lee


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
18
Benzylated and prenylated flavonoids from the root barks of Cudrania tricuspidata with pancreatic lipase inhibitory activity.EBI
Chungbuk National University
11
Isolation and Characterization of Dammarane-Type Saponins from Gynostemma pentaphyllum and Their Inhibitory Effects on IL-6-Induced STAT3 Activation.EBI
Chungbuk National University
21
Pancreatic lipase inhibitory constituents from Morus alba leaves and optimization for extraction conditions.EBI
Chungbuk National University
3
Synthesis of 1,5-diarylhaloimidazole analogs and their inhibitory activities against PGE2 production from LPS-treated RAW 264.7 cells.EBI
College of Pharmacy
31
Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization.EBI
TBA
5
Oroxylin A analogs exhibited strong inhibitory activities against iNOS-mediated nitric oxide (NO) production.EBI
Kangwon National University
10
Characteristic of neuraminidase inhibitory xanthones from Cudrania tricuspidata.EBI
Graduate School of Gyeongsang National University
7
Identification of amidoheteroaryls as potent inhibitors of mutant (V600E) B-Raf kinase with in vivo activity.EBI
AstraZeneca
1
Discovery of a novel BLT2 antagonist for the treatment of inflammatory airway diseases.EBI
Korea University
7
Discovery of Pan-peroxisome Proliferator-Activated Receptor Modulators from an Endolichenic Fungus, EBI
Seoul National University
28
Discovery of potent colony-stimulating factor 1 receptor inhibitors by replacement of hinge-binder moieties.EBI
Chung-Ang University
3
Chemical Control of Mammalian Circadian Behavior through Dual Inhibition of Casein Kinase Iα and δ.EBI
Korea Institute of Science and Technology
5
Synthesis and anti-tumor activity of imidazopyrazines as TAK1 inhibitors.EBI
Chung-Ang University
14
Click chemistry for improvement in selectivity of quinazoline-based kinase inhibitors for mutant epidermal growth factor receptors.EBI
Chung-Ang University
8
Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors.EBI
In2Gen
23
Identification of crizotinib derivatives as potent SHIP2 inhibitors for the treatment of Alzheimer's disease.EBI
Korea Institute of Science and Technology
5
Alkylphenyl compoundsBDB
Bristol Myers Squibb
50
Therapeutic agent for FGFR inhibitor-resistant cancerBDB
Taiho Pharmaceutical
15
Small molecule inhibitors of the JAK family of kinasesBDB
Janssen Pharmaceutica
36
4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as TAK1 inhibitors in disease treatmentBDB
Confluence Life Sciences
2
Identification of conformationally sensitive residues essential for inhibition of vesicular monoamine transport by the noncompetitive inhibitor tetrabenazine.BDB
Hebrew University of Jerusalem
57
Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseasesBDB
Cayman Chemical
22
Aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligandsBDB
Gruenenthal
11
Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.BDB
Acadia Pharmaceuticals
9
Hepatitis C virus NS3-4A serine protease inhibitors: use of a P2-P1 cyclopropyl alanine combination for improved potency.BDB
Schering-Plough Research Institute